Filling the need for trusted information on national health issues
A new KFF analysis finds donor government support for global family planning efforts totaled US$1.40 billion in 2020, a decline of US$114 million compared to last year’s level of US$1.52 billion. This decline in donor funding was largely due to the decreased funding from the UK, family planning’s second largest…
Recent policy actions and proposals in Medicaid have renewed focus on the problem of churn, or temporary loss of coverage in which enrollees disenroll and then re-enroll within a short period of time. We find that 10% of full-benefit enrollees have a gap in coverage of less than a year, and rates are higher for children and adults compared to aged and people with disabilities. Churn has implications for access to care as well as administrative costs faced by states.
The emergence of the omicron COVID-19 variant is encouraging many already vaccinated adults to get a recommended booster shot but is providing only a little motivation for unvaccinated adults to get an initial shot, a new KFF COVID-19 Vaccine Monitor quick response survey finds. Fielded from Dec. 15-20 to provide…
This report examines the views and experiences of people in rural, urban and suburban areas related to the pandemic, and finds they hold very different views of the COVID-19 vaccines, particularly when it comes to children.
The Program on Medicaid and the Uninsured is the largest operating program of KFF and serves as a key resource for policymakers, the media, and organizations seeking information on health care for the low-income population and the Medicaid program. Its work focuses on key health policy issues at the national…
This data note explores findings from on an 8-day online search for at home COVID-19 tests at major retailers. The findings are described against the backdrop of the Biden Administration policy requiring plans to cover the cost of these tests. We find that these tests remain hard to find and that this limited availability could negatively affect the success of the reimbursement strategy.
As COVID cases have surged across the United States due to the new Omicron variant, the Biden Administration has stepped up efforts to expand testing capacity including by making at-home COVID tests more available.
The Build Back Better Act (BBBA) includes a range of health and other proposals supported by President Biden, including a proposal to allow the federal government to negotiate the price of some prescription drugs covered under Medicare Part B (administered by physicians) and Medicare Part D (retail outpatient drugs). This brief illustrates the potential scope of the drug price negotiation proposal in the BBBA. This analysis is designed to highlight the types of Medicare-covered drugs that could be subject to negotiation, and which of the current top-spending drugs covered by Part B and Part D could be subject to price negotiation, and in what years, if the BBBA is enacted.
As part of an effort to promote equitable access to tests, the Biden administration launched a testing supply program that has set aside 25 million rapid at-home self-test kits for distribution by community health centers. Under the program, health centers will be distributing self-tests to patients and community members, with a focus on populations at greatest risk from adverse outcomes related to COVID-19.
The National Association of Black Journalists has recognized KFF’s Kaiser Health News and two of its editorial partners with a 2021 “Salute to Excellence” award for a radio story about how children are taught to cope and survive in communities beset by gun violence. The story, Teaching Kids To Hide…
